Ranitidine use is associated with increased morbidity and mortality in very low birthweight infants.
Publication
, Journal Article
Cotten, CM; Malcolm, WF
Published in: Evid Based Med
February 2013
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Evid Based Med
DOI
EISSN
1473-6810
Publication Date
February 2013
Volume
18
Issue
1
Start / End Page
36 / 37
Location
England
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Cotten, C. M., & Malcolm, W. F. (2013). Ranitidine use is associated with increased morbidity and mortality in very low birthweight infants. Evid Based Med, 18(1), 36–37. https://doi.org/10.1136/ebmed-2012-100622
Cotten, C Michael, and William F. Malcolm. “Ranitidine use is associated with increased morbidity and mortality in very low birthweight infants.” Evid Based Med 18, no. 1 (February 2013): 36–37. https://doi.org/10.1136/ebmed-2012-100622.
Cotten CM, Malcolm WF. Ranitidine use is associated with increased morbidity and mortality in very low birthweight infants. Evid Based Med. 2013 Feb;18(1):36–7.
Cotten, C. Michael, and William F. Malcolm. “Ranitidine use is associated with increased morbidity and mortality in very low birthweight infants.” Evid Based Med, vol. 18, no. 1, Feb. 2013, pp. 36–37. Pubmed, doi:10.1136/ebmed-2012-100622.
Cotten CM, Malcolm WF. Ranitidine use is associated with increased morbidity and mortality in very low birthweight infants. Evid Based Med. 2013 Feb;18(1):36–37.
Published In
Evid Based Med
DOI
EISSN
1473-6810
Publication Date
February 2013
Volume
18
Issue
1
Start / End Page
36 / 37
Location
England
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 1103 Clinical Sciences